SOLSTICE EVIDENCE ENGINE / Ground Truth Verification

Ssri Evidence-grounded verification of convergence findings

Claims Tested
21
Papers Found
188
API Calls
107
Convergence Conf.
79%
Grounded Conf.
14%
Delta
-65%

Confidence Comparison

Evidence Verdict
Convergence overclaimed by 65%.
Convergence Said
79%
Evidence Says
14%
Δ
Overclaimed
-65%

Per-Claim Evidence

ClaimConv.GroundedDeltaPapersS/C/NFlags
C001
Multiple worldviews independently agree that the primary cause of the 2-6 week delay in SSRI efficacy involves downstrea...
85% 0% -85% 0 0/0/0 OVERCLAIMED LOW EVIDENCE
Support: —  |  Contradiction:
C002
The actual occurrence during the SSRI delay involves serotonin-triggered initiation of neuroadaptive changes in the brai...
85% 10% -75% 9 3/0/4 OVERCLAIMED
Support: Distinct genetic responses to fluoxetine sertraline and citalopram in mouse cort (2025)  |  Contradiction:
C003
Overall, the consensus is that serotonin acts as a trigger, not the sole mechanism. It initiates neuroplastic and adapti...
85% 7% -78% 11 3/0/6 OVERCLAIMED
Support: Revisiting Abdominal Pain in IBS: From Pathophysiology to Targeted Management wi (2026)  |  Contradiction:
C004
The Castren lab's data on TrkB direct binding is contentious. While some worldviews propose SSRIs as potential TrkB modu...
85% 0% -85% 0 0/0/0 OVERCLAIMED LOW EVIDENCE
Support: —  |  Contradiction:
C005
The primary mechanism attributed to the 2-6 week therapeutic delay of SSRIs involves synaptic plasticity and neurogenesi...
80% 49% -31% 15 9/0/5 OVERCLAIMED
Support: Advances in the prevalence and treatment of depression for adolescents: a review (2025)  |  Contradiction:
C006
The role of other neurotransmitter systems, such as glutamate and GABA, is increasingly recognized but not fully explore...
80% 13% -67% 15 5/1/7 OVERCLAIMED
Support: Advances in the prevalence and treatment of depression for adolescents: a review (2025)  |  Contradiction: The role of serotonergic signaling on phototactic and locomotor behavior in Daph (2023)
C007
The delayed antidepressant effects of SSRIs (Selective Serotonin Reuptake Inhibitors) are hypothesized to primarily resu...
75% 18% -57% 10 6/0/2 OVERCLAIMED
Support: Multidisciplinary Expert Guidance for the Management of Severe Bleeding on Oral (2025)  |  Contradiction:
C008
The interaction of hippocampal neurogenesis with other processes like synaptogenesis and gliogenesis is underexplored. T...
75% 24% -51% 22 9/0/12 OVERCLAIMED
Support: Strigolactones in Plants and Their Interaction with the Ecological Microbiome in (2022)  |  Contradiction:
C009
The most frequently cited mechanism for the delayed antidepressant effects of SSRIs involves the desensitization of sero...
70% 0% -70% 2 0/0/2 OVERCLAIMED LOW EVIDENCE
Support: —  |  Contradiction:
C010
The field might be overlooking the role of other neurotransmitter systems, such as glutamatergic and GABAergic systems, ...
70% 27% -43% 10 5/0/3 OVERCLAIMED
Support: Antidepressants for pain management in adults with chronic pain: a network meta- (2023)  |  Contradiction:
C011
The delayed therapeutic effects of SSRIs are primarily due to neuroadaptive changes rather than immediate synaptic serot...
80% 36% -44% 10 7/0/3 OVERCLAIMED
Support: A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, (2025)  |  Contradiction:
C012
The role of the gut-brain axis and the microbiome. Emerging evidence indicates these may influence brain chemistry and m...
80% 0% -80% 9 3/0/2 OVERCLAIMED
Support: Unveiling the Anti-Inflammatory Effects of Antidepressants: A Systematic Review (2025)  |  Contradiction:
C013
The delay in the therapeutic effects of SSRIs (Selective Serotonin Reuptake Inhibitors) is hypothesized to involve a com...
85% 0% -85% 13 4/0/7 OVERCLAIMED
Support: Clinical uses of Bupropion in patients with Parkinson's disease and comorbid dep (2022)  |  Contradiction:
C014
The role of the gut-brain axis in SSRI efficacy remains under-explored. Alterations in gut microbiota may interact with ...
85% 5% -80% 7 3/0/2 OVERCLAIMED
Support: The role of gut microbiota in depression: an analysis of the gut-brain axis. (2023)  |  Contradiction:
C015
The primary mechanism behind the therapeutic delay of SSRIs involves downstream neuroadaptive changes, not the immediate...
75% 49% -26% 15 9/0/5 OVERCLAIMED
Support: Advances in the prevalence and treatment of depression for adolescents: a review (2025)  |  Contradiction:
C016
One overlooked area is the interaction of SSRIs with TrkB and potential effects through other non-serotonergic pathways,...
75% 0% -75% 0 0/0/0 OVERCLAIMED LOW EVIDENCE
Support: —  |  Contradiction:
C017
The predominant hypothesis attributes the therapeutic delay of SSRIs to neuroplastic changes in the brain rather than im...
84% 30% -54% 15 7/1/6 OVERCLAIMED
Support: Network Meta-Analysis Indicates Superior Effects of Omega-3 Polyunsaturated Fatt (2024)  |  Contradiction: Agmatine augmentation in treatment-resistant obsessive-compulsive disorder: a pr (2026)
C018
The role of the gut-brain axis in SSRI treatment efficacy has not been fully explored. Emerging evidence suggests the mi...
84% 0% -84% 9 3/0/2 OVERCLAIMED
Support: Unveiling the Anti-Inflammatory Effects of Antidepressants: A Systematic Review (2025)  |  Contradiction:
C019
SSRIs, or Selective Serotonin Reuptake Inhibitors, increase serotonin levels by inhibiting its reuptake into the presyna...
80% 23% -57% 15 6/1/7 OVERCLAIMED
Support: Network Meta-Analysis Indicates Superior Effects of Omega-3 Polyunsaturated Fatt (2024)  |  Contradiction: Mechanism of action of serotonin selective reuptake inhibitors. Serotonin recept (1998)
C020
The impact of SSRIs on the gut-brain axis has been underexplored. Recent findings suggest that gut microbiota could play...
80% 0% -80% 0 0/0/0 OVERCLAIMED LOW EVIDENCE
Support: —  |  Contradiction:
C021
JUDGMENT SUMMARY1. WINNERDEFENSE 2. SURVIVING ARGUMENTS- Autoreceptor desensitization and HPA axis recalibration are mo...
60% 0% -60% 1 0/0/0 OVERCLAIMED LOW EVIDENCE
Support: —  |  Contradiction:

Falsification Results

TargetStrategyPapersContradictionVerdict
** Multiple worldviews independently agree that the primary cause of the 2-6 week delay in SSRI efficacy involves downstream neuroadaptive changes. negation 5 none SURVIVES
Therapeutic claims trial_check 5 weak SURVIVES

Methodology

Evidence Engine v1.0 — Phases 1-2 are LLM-free (pure API queries). Phase 3 uses LLM to classify papers as supporting/contradicting/neutral. Phase 4 actively searches for contradicting evidence. Grounded confidence is computed from evidence pyramid weights, citation counts, recency, and support ratios — not extracted from LLM-generated text.

APIs used: PubMed E-utilities, Semantic Scholar, ClinicalTrials.gov, Europe PMC
Evidence pyramid weights: Systematic Review (1.0) > RCT (0.85) > Clinical Trial (0.70) > Cohort (0.55) > Review (0.40) > Case Report (0.30) > Preprint (0.25)
Runtime: 50s (0.8m)
All Reports